Early first‐line treatment response and subsequent disability worsening in relapsing–remitting multiple sclerosis

Access to the CombiRx dataset can be requested from the Coordinating Center or MS Center at the University of Alabama at Birmingham (Birmingham, Alabama, USA) by completing a data use agreement that is reviewed by a committee overseeing the use of the data. Qualified researchers must obtain appropriate institutional review board approval for the study request. Depending on the complexity of the request, researchers may need to cover the cost of producing the deidentified data.

留言 (0)

沒有登入
gif